ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Neovacs

Neovacs (ALNEV)

1.214
-0.1256
(-9.38%)
終了 7月11日 12:30AM

Neovacs (ALNEV) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
1.214
( -9.38% )
買値
1.102
売値
1.22
出来高
8,935
平均取引量 (3 か月)
4,606 €
財務取引量
-
1.0922 日の範囲 1.24
0.0002 52 週間の範囲 1.8998
時価総額
企業価値
335.753k
前日終値
1.3396
始値
1.13
最終取引時間
VWAP
-
歳入
199.27k
純利益
-4.36M
発行済株式数
159,064
浮動株比率 (%)
-
機関投資家保有比率 (%)
-
配当利回り
PER
-
株価売上高倍率 (PSR)
1.02
1 株当たり利益 (EPS)
-
ベータ
-1.22k

Neovacs について

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune diseases using its Kinoid technology. The company’s product pipeline includes Kinoid,... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune diseases using its Kinoid technology. The company’s product pipeline includes Kinoid, a therapeutic vaccine which allows the immune system to generate natural polyclonal antibodies. IFNa Kinoid, an anti-interferon alpha vaccine which completed Phase I / IIa and IIb clinical trial for the treatment of lupus erythematosus; and Phase IIa clinical trial for the treatment of asthma, dermatomyositis, and all food allergies; and kinoid vaccine that simultaneously targets IL-4 and IL-13 allergies. The company was founded in 1993 and is based in Suresnes, France. 詳細を表示

セクター
Health Care
業界
-
ウェブサイト
本社
Suresnes, France
設立
1993
Neovacs is listed in the Health Care sector of the ユーロネクスト with ticker ALNEV. The last closing price for Neovacs was 1.34 €. Over the last year, Neovacs shares have traded in a share price range of 0.0002 € to 1.8998 €.

Neovacs currently has 159,064 shares in issue. The market capitalisation of Neovacs is 193,103.70 € .

ALNEV 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.206-14.50704225351.421.481.092291331.29592738DE
41.21386069000.00021.89980.000274516760.00083538DE
121.21386069000.00021.89980.0002240127830.00029537DE
261.20717242.85714290.0071.89980.0002262783410.00112799DE
520.16415.6190476191.051.89980.0002138082860.00206358DE
1560.804196.0975609760.413.20.0001183019630.00202109DE
2601.209325729.7872340.00474.3990.0001556350700.00232175DE

ALNEV - Frequently Asked Questions (FAQ)

What is the current Neovacs share price?
The current share price of Neovacs is 1.214 €
How many Neovacs shares are in issue?
Neovacs has 159,064 shares in issue
What is the market cap of Neovacs?
The market capitalisation of Neovacs is EUR 193.1k
What is the 1 year trading range for Neovacs share price?
Neovacs has traded in the range of 0.0002 € to 1.8998 € during the past year
What is the cash to sales ratio of Neovacs?
The cash to sales ratio of Neovacs is 1.02
What is the registered address of Neovacs?
The registered address for Neovacs is 14 Rue de la Republic FR, Suresnes, Ile-de-France, 92150
What is the Neovacs website address?
The website address for Neovacs is www.neovacs.com

ALNEV 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock